6
S. Kuwahara et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
1635, 1581, 1503, 1455, 1323, 1242, 1151, 1063, 1029, 886, 845,
805, 630 cmÀ1; FAB-MS (matrix: m-NBA) m/z 276 ([M(79Br)]+,
30%), 278 ([M(81Br)]+, 30%); Anal. Calcd for C14H13BrO: C, 60.67;
H, 4.73. Found. C, 60.62; H, 4.73.
J1 = 16.4 Hz, J2 = 2.8 Hz, 1H), 1.90–1.84 (m, 2H), 1.56 (d,
J = 12.6 Hz, 1H), 1.40–1.24 (m, 6H), 0.87–0.74 (m, 4H), 0.64–0.40
(m, 10H); 13C NMR (100 MHz, CDCl3) d 167.2, 158.2, 146.6, 143.4,
140.5, 135.3, 134.2, 132.8, 130.3, 130.0, 129.2, 129.0, 128.9, 128.1,
127.3, 126.4, 124.8, 120.0, 119.0, 118.7, 112.6, 83.6, 77.6, 47.0,
40.2, 39.8, 38.4, 34.0, 31.1, 25.6, 23.0, 21.9, 20.4, 19.6, 16.3; IR
(KBr) mmax 3819, 2732, 3647, 2955, 1693, 1606, 1557, 1505, 1454,
1408, 1309, 1279, 1213, 1140, 1069, 803, 758, 697, 567, 520, 462,
452, 424, 417 cmÀ1; FAB-MS (matrix m-NBA) m/z 610 ([M(79Br)]+,
4.3.2. ( )-cis-7-Bromo-2-methyl-2,3-dihydro-1H-cyclopenta
[a]naphthalen-1-ol 8
White solid; mp 149–150 °C; 1H NMR (400 MHz, CDCl3) d 8.01
(d, J = 2.0 Hz, 1H), 7.98 (d, J = 8.9 Hz, 1H), 7.68 (d, J = 8.3 Hz, 1H),
7.60 (dd, J1 = 8.9 Hz, J2 = 2.0 Hz, 1H), 7.39 (d, J = 8.3 Hz, 1H), 5.48
(t, J = 8.3 Hz, 1H), 3.10 (dd, J1 = 16.1 Hz, J2 = 7.8 Hz, 1H), 2.84 (dd,
J1 = 16.1 Hz, J2 = 8.5 Hz, 1H), 2.66 (m, 1H), 1.46 (d, J = 7.1 Hz, 1H),
1.30 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) d 142.3, 139.8,
134.1, 130.5, 129.9, 128.8, 128.3, 125.7, 124.5, 119.0, 76.2, 39.2,
39.1, 13.9; IR (KBr) mmax 3191, 2961, 2926, 2899, 1585, 1501,
1435, 1352, 1313, 1259, 1159, 1097, 1071, 1005, 901, 875, 824,
810, 780, 759, 680, 668, 642, 602, 563 cmÀ1; FAB-MS (matrix: m-
NBA) m/z 276 ([M(79Br)]+, 50%), 278 ([M(81Br)]+, 50%); Anal. Calcd
for C14H13BrO: C, 60.67; H, 4.73. Found. C, 60.55; H, 4.74.
3%), 612 ([M(81Br)]+, 3%); [ 25 = +102.5 (c 1.08, CHCl3); Anal. Calcd
a]
D
for C37H39BrO3: C, 72.66; H, 6.43. Found: C, 72.36; H, 6.42.
4.4.2. (À)-3-Menthoxybiphenyl-4-carboxylic acid ester (1S,2S)-
(+)-12a and (1R,2R)-(À)-12b
GP-1 was carried out with alcohol ( )-cis-8 (257 mg,
0.928 mmol), (À)-3-menthoxybiphenyl-4-carboxylic acid acid
(À)-1 (407 mg, 1.15 mmol), DCC (259 mg, 1.27 mmol), and DMAP
(21 mg, 0.17 mmol) in CH2Cl2 (3 mL) at room temperature over-
night. The crude product was purified by column chromatography
on silica gel (hexane/EtOAc, 10:1). The diastereomeric esters
obtained were separated by HPLC on octadecylsilane (YMC-Pack
Pro C18 RS (250 Â 10 mm), eluent: acetonitrile, separation factor
4.4. General procedure for the preparation of (À)-3-
menthoxybiphenyl-4-carboxylic acid esters (GP-1)
a
= 1.06, resolution factor Rs = 1.07), giving (1S,2S)-(+)-12a
4.4.1. (À)-3-Menthoxybiphenyl-4-carboxylic acid esters (1S,2R)-
(À)-7a and (1R,2S)-(+)-7b
(238 mg, 42%) as the ester eluted first and (1R,2R)-(À)-12b
(263 mg, 46%) as the ester eluted second.
A mixture of alcohol ( )-trans-6 (0.159 g, 0.575 mmol), (À)-3-
menthoxybiphenyl-4-carboxylic acid acid (À)-1 (0.264 g,
0.748 mmol), DCC (0.188 g, 0.909 mmol), and DMAP (0.035 g,
0.287 mmol) in CH2Cl2 (2 mL) was stirred at room temperature
overnight. After the addition of a small amount of water, the mixture
was stirred for 2 h, diluted with EtOAc, and filtered with Celite,
which was washed with EtOAc. The organic layer was dried over
anhydrous Na2SO4, and evaporated to dryness. The crude product
was purified by column chromatography on silica gel (hexane/
EtOAc, 20:1). The diastereomeric esters obtained were separated
by HPLC on octadecylsilane (YMC-Pack Pro C18 RS (250 Â 10 mm),
4.4.2.1. (À)-3-Menthoxybiphenyl-4-carboxylic acid ester (1S,2S)-
(+)-12a.
White solid; mp 129–130 °C; 1H NMR (400 MHz,
CDCl3) d 8.02 (d, J = 2.0 Hz, 1H), 7.89 (d, J = 8.9 Hz, 2H), 7.76–7.69
(m, 2H), 7.58–7.48 (m, 3H), 7.47–7.34 (m, 4H), 7.11–7.07 (m,
2H), 7.05 (d, J = 6.4 Hz, 2H), 4.09 (ddd, J = 10.6, 10.6, 4.4 Hz, 1H),,
3.24–3.12 (m, 1H), 2.99–2.85 (m, 2H), 1.98–1.82 (m, 2H), 1.65–
1.57 (m, 2H), 1.37–1.23 (m, 4H), 1.05–0.86 (m, 2H), 0.83–0.56
(m, 12H); 13C NMR (100 MHz, CDCl3) d 167.1, 158.2, 146.5, 143.7,
140.5, 137.0, 134.1, 132.7, 130.3, 130.1, 128.9, 128.8, 128.7,
128.1, 127.3, 126.4, 124.3, 120.3, 119.1, 118.8, 112.9, 77.8, 77.6,
47.0, 40.0, 39.4, 38.3, 34.1, 31.1, 25.6, 23.1, 21.9, 20.6, 16.3, 14.3;
IR (KBr) mmax 2954, 2924, 2864, 1690, 1605, 1557, 1515, 1481,
1454, 1405, 1307, 1270, 1237, 1213, 1139, 1074, 990, 914, 810,
757, 721, 697, 650, 604, 556, 534 cmÀ1; FAB-MS (matrix: DTT:
TG = 1:1) m/z 633 ([M(79Br)+Na]+, 20%), 635 ([M(81Br)+Na]+, 20%);
eluent: acetonitrile, separation factor
a = 1.12, resolution factor
Rs = 1.86), giving (1S,2R)-(À)-7a (0.152 g, 43%) as the ester eluted
first and (1R,2S)-(+)-7b (0.124 g, 35%) as the one eluted second.
4.4.1.1.
(À)-3-Menthoxybiphenyl-4-carboxylic
acid
Colorless needles; mp 145–146 °C; 1H NMR
(ppm) 8.03 (d, J = 1.9 Hz, 1H), 7.84 (d,
ester
(1S,2R)-(À)-7a.
[a]
25 = +89.9 (c 0.68, CHCl3); Anal. Calcd for C37H39BrO3: C, 72.66;
D
(400 MHz, CDCl3)
d
H, 6.43. Found: C, 72.49; H, 6.40.
J = 8.9 Hz, 1H), 7.74 (dd, J1 = 8.3 Hz, J2 = 1.9 Hz, 2H), 7.57–7.52 (m,
2H), 7.46–7.35 (m, 5H), 7.10–7.08 (m, 2H), 6.66 (s, 1H), 4.09
(ddd, J = 10.7, 10.7, 4.4 Hz, 1H), 3.52 (dd, J1 = 16.5 Hz, J2 = 7.8 Hz,
1H), 2.78–2.75 (m, 1H), 2.66 (dd, J1 = 16.5 Hz, J2 = 2.3 Hz, 1H),
1.96–1.93 (m, 2H), 1.62–1.56 (m, 6H), 1.28 (d, J = 7.4 Hz, 3H),
1.09–0.92 (m, 2H), 0.64–0.40 (m, 12H); 13C NMR (100 MHz, CDCl3)
d 167.0, 158.1, 146.2, 143.5, 140.5, 135.1, 134.2, 131.9, 130.4,
130.1, 129.2, 129.1, 128.9, 128.0, 127.3, 126.1, 124.7, 121.1,
119.1, 118.9, 113.2, 83.4, 78.5, 47.5, 40.4, 39.9, 39.7, 34.2, 31.3,
25.7, 23.2, 22.0, 20.6, 19.6, 16.3; IR (KBr) mmax 3420, 3064, 2954,
2868, 1684, 1607, 1557, 1505, 1479, 1450, 1409, 1312, 1279,
1247, 1216, 1140, 1093, 1047, 974, 893, 851, 806, 759, 725, 696,
607, 508, 418 cmÀ1; FAB-MS (matrix m-NBA) m/z 610 ([M(79Br)]+,
4.4.2.2.
(1R,2R)-(À)-12b.
(À)-3-Menthoxybiphenyl-4-carboxylic
acid
ester
White solid; mp 72–73 °C; 1H NMR
(400 MHz, CDCl3) d 8.02 (d, J = 2.0 Hz, 1H), 7.89–7.82 (m, 2H),
7.72 (d, J = 8.3 Hz, 1H), 7.58–7.48 (m, 3H), 7.47–7.34 (m, 4H),
7.11 (dd, J1 = 8.1 Hz, J2 = 1.5 Hz, 2H), 7.07–7.02 (m, 2H), 4.18
(ddd, J = 10.7, 10.7, 4.4 Hz, 1H), 3.26–3.13 (m, 1H), 3.12–2.86 (m,
2H), 1.98–1.85 (m, 1H), 1.87–1.77 (m, 1H), 1.52–1.39 (m, 2H),
1.33–1.15 (m, 4H), 0.92–0.30 (m, 13H); 13C NMR (100 MHz, CDCl3)
d 167.1, 158.2, 146.5, 143.7, 140.5, 137.0, 134.1, 132.7, 130.3,
130.1, 128.9, 128.7, 128.1, 127.3, 126.4, 124.3, 120.3, 119.1,
118.8, 112.9, 77.8, 77.7, 47.0, 40.0, 39.4, 38.3, 34.1, 31.1, 25.6,
23.1, 21.9, 20.6, 16.3, 14.3; IR (KBr) mmax 2955, 2927, 2869, 1962,
1606, 1557, 1505, 1481, 1453, 1407, 1345, 1308, 1279, 1247,
1213, 1140, 1096, 1073, 1048, 991, 913, 893, 803, 757, 723, 697,
554 cmÀ1 FAB-MS (matrix: DTT:TG = 1:1) m/z 633 ([M(79Br)+Na]+,
3%), 612 ([M(81Br)]+, 3%); [
a
]
D
25 = À164.1 (c 1.70, CHCl3); Anal. Calcd
for C37H39BrO3: C, 72.66; H, 6.43. Found: C, 72.42; H, 6.47.
4.4.1.2.
(1R,2S)-(+)-7b.
(À)-3-Menthoxybiphenyl-4-carboxylic
acid
ester
5%), 635 ([M(81Br)+Na]+, 5%); [
Calcd for C37H39BrO3: C, 72.66; H, 6.43. Found. C, 72.66; H, 6.45.
a]
25 = À186.4 (c 0.77, CHCl3); Anal.
D
White solid; mp 75–76 °C; 1H NMR
(400 MHz, CDCl3) d 8.04 (d, J = 2.0 Hz, 1H), 7.90 (d, J = 8.1 Hz, 2H),
7.80 (d, J = 8.9 Hz, 1H), 7.74 (m, J = 8.4 Hz, 1H), 7.55–7.52 (m, 3H),
7.46–7.36 (m, 4H), 7.12 (dd, J1 = 8.1 Hz, J2 = 1.5 Hz, 1H), 7.04 (d,
J = 1.2 Hz, 1H), 6.61 (s, 1H), 4.03 (ddd, J = 10.6, 10.6, 4.2 Hz, 1H),
3.52 (dd, J1 = 16.4 Hz, J2 = 7.4 Hz, 1H), 2.80–2.76 (m, 1H), 2.67 (dd,
4.4.3. (À)-3-Menthoxybiphenyl-4-carboxylic acid esters (S)-(À)-
13a and (R)-(À)-13b
GP-1 was carried out with alcohol ( )-9 (59 mg, 0.33 mmol),
(À)-3-menthoxybiphenyl-4-carboxylic acid acid (À)-1 (145 mg,